BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8869189)

  • 1. Growth and endocrine sequelae of craniopharyngioma.
    DeVile CJ; Grant DB; Hayward RD; Stanhope R
    Arch Dis Child; 1996 Aug; 75(2):108-14. PubMed ID: 8869189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study.
    Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A
    J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the management of craniopharyngioma in children. An endocrinological approach to the treatment.
    Kang JK; Song JU
    Childs Nerv Syst; 1988 Jun; 4(3):135-8. PubMed ID: 3396019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Craniopharyngioma: presentation and endocrine sequelae in 36 children.
    de Vries L; Lazar L; Phillip M
    J Pediatr Endocrinol Metab; 2003 Jun; 16(5):703-10. PubMed ID: 12880119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Craniopharyngioma in children. Endocrine evaluation and treatment. Apropos of 37 cases].
    Brauner R; Malandry F; Rappaport R; Pierre-Kahn A; Hirsch JF
    Arch Fr Pediatr; 1987 Nov; 44(9):765-9. PubMed ID: 3446067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrinological outcome of different treatment options in children with craniopharyngioma: a retrospective analysis of 66 cases.
    Gonc EN; Yordam N; Ozon A; Alikasifoglu A; Kandemir N
    Pediatr Neurosurg; 2004; 40(3):112-9. PubMed ID: 15367800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endocrine sequelae of surgically treated craniopharyngioma in children. Study of 7 recent cases].
    Pierron H; Charvet JP; Jacquet P; Raybaud C; Orsini A
    Pediatrie; 1971 Dec; 26(8):823-37. PubMed ID: 4333167
    [No Abstract]   [Full Text] [Related]  

  • 8. Growth arrest despite growth hormone replacement, post-craniopharyngioma surgery.
    DeVile CJ; Hayward RD; Neville BG; Grant DB; Stanhope R
    J R Soc Med; 1995 Apr; 88(4):227P-228P. PubMed ID: 7745571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine function, morbidity, and mortality after surgery for craniopharyngioma.
    Lyen KR; Grant DB
    Arch Dis Child; 1982 Nov; 57(11):837-41. PubMed ID: 6293388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term neurological, visual, and endocrine outcomes following transnasal resection of craniopharyngioma.
    Chakrabarti I; Amar AP; Couldwell W; Weiss MH
    J Neurosurg; 2005 Apr; 102(4):650-7. PubMed ID: 15871507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine Disorders Developing after Surgical Intervention of Craniopharyngioma in Children.
    Shohdy KS; Rashad W
    Pediatr Endocrinol Rev; 2017 Mar; 14(3):298-301. PubMed ID: 28508600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours.
    Spoudeas HA; Charmandari E; Brook CG
    Med Pediatr Oncol; 2003 Apr; 40(4):224-9. PubMed ID: 12555249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine sequelae of childhood craniopharyngioma.
    Bin-Abbas B; Mawlawi H; Sakati N; Khafaja Y; Chaudhary MA; Al-Ashwal A
    J Pediatr Endocrinol Metab; 2001; 14(7):869-74. PubMed ID: 11515727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of the surgical treatment of craniopharyngioma: the experience at the Policlinico Gemelli, Catholic University, Rome.
    Caldarelli M; Massimi L; Tamburrini G; Cappa M; Di Rocco C
    Childs Nerv Syst; 2005 Aug; 21(8-9):747-57. PubMed ID: 15995885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The endocrine outcome after surgical removal of craniopharyngiomas.
    Curtis J; Daneman D; Hoffman HJ; Ehrlich RM
    Pediatr Neurosurg; 1994; 21 Suppl 1():24-7. PubMed ID: 7841075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood craniopharyngioma in Macedonia: incidence and outcome after subtotal resection and cranial irradiation.
    Gucev ZS; Danilovski D; Tasic V; Ugrinovski J; Nastova V; Jancevska A; Krstevska-Konstantinova M; Pop-Jordanova N; Kirovski I
    World J Pediatr; 2011 Feb; 7(1):74-8. PubMed ID: 21191780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pre- and postoperative endocrine function in children with craniopharyngioma ].
    Lucas C; Benderitter T; Choux M
    Arch Fr Pediatr; 1982 May; 39(5):303-7. PubMed ID: 7125828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final height and growth hormone secretion after completion of growth hormone therapy in patients with idiopathic growth hormone deficiency and with abnormalities of the hypothalamic-pituitary region.
    Hilczer M; Smyczynska J; Stawerska R; Lewinski A
    Neuro Endocrinol Lett; 2005 Feb; 26(1):19-24. PubMed ID: 15726014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine manifestations of craniopharyngioma.
    Halac I; Zimmerman D
    Childs Nerv Syst; 2005 Aug; 21(8-9):640-8. PubMed ID: 16047216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endocrine sequelae after treatment of pediatric cancer: From childhood to adulthood].
    Thomas-Teinturier C; Salenave S
    Bull Cancer; 2015; 102(7-8):612-21. PubMed ID: 25981322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.